Clinical Trials Logo

Osteoarthritis clinical trials

View clinical trials related to Osteoarthritis.

Filter by:

NCT ID: NCT06233630 Recruiting - Knee Osteoarthritis Clinical Trials

Erector Spinae Plane Block vs. iPACK Block With Adductor Canal Block for Total Knee Arthroplasty

Start date: March 30, 2024
Phase: Phase 4
Study type: Interventional

Effect of Erector Spinae Plane Block and iPACK block with Adductor Canal Block on pain management, and NLR and PLR following knee arthroplasty

NCT ID: NCT06233474 Recruiting - Clinical trials for Osteoarthritis, Knee

Study of Intra-articular Allocetra in Knee Osteoarthritis

Start date: January 26, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This is a double blind, randomized,multi-center study to evaluate the safety and efficacy of intra-articular administration of Allocetra compared to placebo in patients with symptomatic knee osteoarthritis.

NCT ID: NCT06233175 Recruiting - Knee Osteoarthritis Clinical Trials

Combined Kinetic Chain Exercises on Knee Osteoarthritis

Start date: January 30, 2024
Phase: N/A
Study type: Interventional

study will be conducted at faculty of physical therapy cairo university to investigate the effect of combined kinetic chain exercises on static and dynamic hamstring and quadriceps strength in knee osteoarthritis patients

NCT ID: NCT06231758 Recruiting - Clinical trials for Osteo Arthritis Knee

Metformin Safety and Efficacy in Osteoarthritis.

Start date: January 30, 2024
Phase: Phase 3
Study type: Interventional

Knee osteoarthritis (OA) is a chronic, painful disease associated with considerable morbidity, costs and disability. It is estimated that over a third of people aged over 60 have radiographic knee OA2 and over 50% of these with knee OA will go on to have a total knee replacement in their lifetime. At present there are no licensed treatments that alter disease progress and management is primarily concerned with symptom control to retain or improve joint function, although a trial of strontium ranelate showed promising results.

NCT ID: NCT06229951 Not yet recruiting - Clinical trials for Osteo Arthritis Knee

Hydrolyzed Collagen and Undenatured Collagen Type II in OA Knee

Start date: January 20, 2024
Phase: N/A
Study type: Interventional

Randomized controlled trial Targeted patients who come to receive treatment for osteoarthritis that meets the research indications will be assigned to a random group by the box of 4 randomization method, with a sequence that is randomly generated by a computer. The groups are divided into two groups: Group 1: Patients who have taken 480 mg of hydrolyzed collagen and 20 mg of undenatured type II collagen Group 2: Control patients will take placebo Primary outcome : Pain level

NCT ID: NCT06229691 Recruiting - Clinical trials for Osteoarthritis, Knee

Muscle Fatigability and Trip-specific Fall Risk in Adults With Knee Osteoarthritis

Start date: May 2, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about how fatigue affects the risk of falling in adults aged 55-70 years with and without knee osteoarthritis. The main questions this trial aims to answer are: - Does fatigue increase the risk of tripping while walking? and - Does fatigue increase the risk of falling in response to a trip while walking? Participants will - Complete questionnaires - Wear a device that measures physical activity for 5-7 days - Complete a 30 minute walk on a treadmill - Complete the following before and after the treadmill walk: - Computer test to measure mental fatigue - Maximal strength testing - Balance test Researchers will compare adults with and without knee osteoarthritis to see if fall risk in adults with knee osteoarthritis is affected more by walking activity compared to adults without knee osteoarthritis.

NCT ID: NCT06228612 Completed - Osteoarthritis Clinical Trials

Vacuum Therapy and Stabilization Splints Efficacious for the Management of Temporo-mandibular Joint Osteoarthritis

Start date: January 20, 2021
Phase: N/A
Study type: Interventional

The aim of this study was to determine and compare the clinical efficacy of VT and STT alone or in combination for the patients with temporo-mandibular joint (TMJ) osteoarthritis.

NCT ID: NCT06228573 Not yet recruiting - Knee Osteoarthritis Clinical Trials

Transcranial Direct Current Stimulation and Yoga for Knee Osteoarthritis

Start date: May 15, 2024
Phase: N/A
Study type: Interventional

People with knee arthritis often experience constant pain, and current treatments aren't very effective. This can lead to limited movement and more health problems. Knee arthritis is a big part of healthcare costs in Canada, and its pain is a major reason people see doctors. The pain is linked to complex nervous system changes, making current treatments, like exercise, not very successful. To address this, researchers suggest a new approach combining two things: a brain stimulation technique called Transcranial Direct Current Stimulation (tDCS) and yoga. TDCS helps with pain by changing how the brain works, and yoga, a safe practice, focuses on overall well-being. Together, the investigators aim to improve how the nervous system works from top to bottom. The research project wants to change how the arthritis pain is being managed by focusing on how it works. The investigators plan to test this combo in a study comparing real tDCS plus yoga with fake tDCS plus yoga. The investigators will look not only at pain but also at other measures related to pain and how the nervous system works. This new mix could be a meaningful way to reduce pain for people with knee arthritis.

NCT ID: NCT06228274 Completed - Knee Osteoarthritis Clinical Trials

Assessment of Safety and Efficacy of ARTHRUM 2.5% for Treatment of Painful Osteoarthritis of the Knee

ART-ONE75
Start date: March 2013
Phase:
Study type: Observational

ARTHRUM 2.5% MONO-INJECTION as symptomatic treatment by joint injection extends the conservative therapeutic arsenal in Knee osteoarthritis. The reduction of functional limits and disabilities induced by knee osteoarthritis as well as improvement of quality of life of patients is a public health need registered amongst the priorities established by the French law of 9 August 2004 relative to Public Health policy. However, the response to this need is not limited to treatment with health products. This prospective, open, multi-centre trial of the real-life efficacy of ARTHRUM 2.5% aims to demonstrate the efficacy of a single joint injection of this treatment on pain, during 6 months, in the symptomatic treatment of patients suffering from Knee osteoarthritis

NCT ID: NCT06227195 Completed - Osteoarthritis Clinical Trials

Mechanism of IL-10 Pathway-mediated Regulatory B Cell Dysfunction in Osteoarthritis

Start date: January 1, 2019
Phase:
Study type: Observational

Our previous work has shown that Treg function is impaired in OA patients, but the cause of Treg deficiency has not been investigated. Since Breg has been shown to promote Treg differentiation and tissue repair, it is highly likely that the absence of the immunomodulatory effect of Breg in OA patients leads to impaired Treg differentiation. Based on the above data, we hypothesized that Breg plays a protective role in the course of OA by regulating T cell composition and promoting Treg differentiation through the secretion of anti-inflammatory factor IL-10